ENGINEERED CD19-CAR NK CELLS AS AN OFF-THE-SHELF ALTERNATIVE TO B CELL LEUKEMIA AND LYMPHOMA TREATMENT R.N. Silvestre, J. Eitler, D.M.C. Fantacini, K.C.R. Malmegrim, K. Swiech, D.T. Covas, T. Tonn, V. Picanço-Castro

T CELLS ENGINEERED TO EXPRESS A CAR ANTI-GD2 AND THE COSTIMULATORY MOLECULE GITRL ERADICATE GLIOBLASTOMA CELLS AND ARE IFNY PRODUCERS IP Furtado, RM Silveira, H Brand, R Rossetti, DMC Fantacini, LEB Souza, DT Covas

Novelty in improvement of CAR T cell-based immunotherapy with the aid of CRISPR system Abbas Hajifathali, Maryam Vahdat Lasemi, Maryam Mehravar, Mohammad Reza Moshari, Afshin Mohammad Alizadeh, Elham Roshandel